REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Sorepa Laboratories (Lithuania)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: UAB Sorepa Laboratories Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Sorepa Laboratories is an enterprise in Lithuania, with the main office in Vilnius. The company operates in the Machinery, Equipment, and Supplies Merchant Wholesalers sector. UAB Sorepa Laboratories was incorporated on December 03, 2009. 3 (2025) employees currently work for UAB Sorepa Laboratories. From the latest financial highlights, UAB Sorepa Laboratories reported a net sales revenue increase of 71.95% in 2024. UAB Sorepa Laboratories’s net profit margin decreased by 0.76% in 2024.

Headquarters
V. A. Graiciuno g. 32
Vilnius; Vilnius county; Postal Code: LT-02244

Contact Details: Purchase the UAB Sorepa Laboratories report to view the information.

Basic Information
Total Employees:
Purchase the UAB Sorepa Laboratories report to view the information.
Registered Capital:
Purchase the UAB Sorepa Laboratories report to view the information.
Financial Auditors:
Purchase the UAB Sorepa Laboratories report to view the information.
Incorporation Date:
December 03, 2009
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Sorepa Laboratories report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
71.95%
Total operating revenue
71.95%
Net Profit (Loss) for the Period
54.2%
Total Equity
100.56%
Net Profit Margin
-0.76%
Return on Equity (ROE)
-15.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?